Lab Reagents
Cytomegalovirus Antibody Laboratories manufactures the cytomegalovirus ab panel? reagents distributed by Genprice. The Cytomegalovirus Ab Panel? reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cytomegalovirus products are available in stock. Specificity: Cytomegalovirus Category: Ab Group: Panel?
Panel? information
Mouse antibody for Cytomegalovirus |
887 |
Virostat |
100 ug |
EUR 431.93 |
Description: This is Mouse monoclonal FITC conjugated antibody against Cytomegalovirus pp65 for WB, ELISA. |
Cytomegalovirus gB recombinant antigen |
8965 |
Virostat |
100 ug |
EUR 608.1 |
Description: This is Cytomegalovirus gB recombinant antigen for ELISA,WB. |
Cytomegalovirus p28 recombinant antigen |
8966 |
Virostat |
100 ug |
EUR 608.1 |
Description: This is Cytomegalovirus p28 recombinant antigen for ELISA,WB. |
Cytomegalovirus p150 recombinant antigen |
8967 |
Virostat |
100 ug |
EUR 608.1 |
Description: This is Cytomegalovirus p150 recombinant antigen for ELISA,WB. |
Cytomegalovirus IgG ELISA Kit |
DEIA013 |
Creative Diagnostics |
96T |
EUR 858 |
Description: The CMV IgG ELISA is intended for use in the detection of Cytomegalovirus Antibody IgG in human serum. |
Cytomegalovirus IgG ELISA Kit |
DEIA326 |
Creative Diagnostics |
96T |
EUR 795.6 |
Description: Enzyme immunoassay for the quantitative determination of IgG antibodies against Cytomegalovirus in human serum and plasma. |
Cytomegalovirus Antibody / CMV / PP65 |
V2332-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2332-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2332SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2333-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2333-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
Cytomegalovirus Antibody / CMV / PP65 |
V2333SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease. |
SeroDetect HCV-Ab Mixed Titer Verification Panel I (15 X 0.25 mL) |
KZMC022 |
Zeptometrix |
15 X 0.25 mL |
EUR 319.58 |
|
Description: Please contact Gentaur in order to receive the datasheet of the product. |